Provided by Tiger Fintech (Singapore) Pte. Ltd.

AzurRx Biopharma Inc.

3.45
+0.0000
Volume:- -
Turnover:2.20M
Market Cap:34.33M
PE:-0.22
High:3.45
Open:3.45
Low:3.45
Close:3.45
Loading ...
Dec 20, 2019

Major Issues Report

Current report, items 5.02 and 5.07
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 14, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 05, 2019

Correspondence

[Cover]Correspondence
Nov 01, 2019

Major Issues Report

Current report, items 3.01 and 5.02
Oct 22, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Oct 17, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 15, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 15, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Oct 11, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Oct 09, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 25, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Aug 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 22, 2019

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Jul 10, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jul 09, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities